Does the media favor AMS or EKF?

In the previous week, EKF Diagnostics had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat EKF Diagnostics' score of 0.34 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Medical Solutions Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EKF Diagnostics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer AMS or CREO?

In the previous week, Advanced Medical Solutions Group and Advanced Medical Solutions Group both had 1 articles in the media. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat Creo Medical Group's score of 0.75 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Medical Solutions Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Creo Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Advanced Medical Solutions Group (AMS) Competitors

GBX 281.52 +0.02 (+0.01%)

As of 12:52 PM Eastern

Compare

AMS vs. NIOX, TSTL, EKF, SPEC, and CREO

Should you buy Advanced Medical Solutions Group stock or one of its competitors? Advanced Medical Solutions Group's main competitors and comparable companies include NIOX Group (NIOX), Tristel (TSTL), EKF Diagnostics (EKF), INSPECS Group (SPEC), and Creo Medical Group (CREO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Advanced Medical Solutions Group compare to NIOX Group?

Advanced Medical Solutions Group (LON:AMS) and NIOX Group (LON:NIOX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Advanced Medical Solutions Group presently has a consensus target price of GBX 270.25, suggesting a potential downside of 4.00%. NIOX Group has a consensus target price of GBX 86, suggesting a potential upside of 25.36%. Given NIOX Group's stronger consensus rating and higher possible upside, analysts clearly believe NIOX Group is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Advanced Medical Solutions Group has a beta of 0.704, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

NIOX Group has lower revenue, but higher earnings than Advanced Medical Solutions Group. NIOX Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28
NIOX Group	£48.70M	5.93	£995.88M	£1.64	41.83

22.7% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 7.6% of NIOX Group shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 5.1% of NIOX Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Advanced Medical Solutions Group had 1 more articles in the media than NIOX Group. MarketBeat recorded 1 mentions for Advanced Medical Solutions Group and 0 mentions for NIOX Group. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat NIOX Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Medical Solutions Group	Positive
NIOX Group	Neutral

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. NIOX Group pays an annual dividend of GBX 1.25 per share and has a dividend yield of 1.8%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. NIOX Group pays out 76.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

NIOX Group has a net margin of 14.37% compared to Advanced Medical Solutions Group's net margin of 4.35%. NIOX Group's return on equity of 10.14% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
NIOX Group	14.37%	10.14%	3.95%

Summary

NIOX Group beats Advanced Medical Solutions Group on 10 of the 18 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Tristel?

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	4.15	£6.54M	£16.24	26.39
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28

22.5% of Tristel shares are held by institutional investors. Comparatively, 22.7% of Advanced Medical Solutions Group shares are held by institutional investors. 21.0% of Tristel shares are held by insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Advanced Medical Solutions Group has a consensus price target of GBX 270.25, indicating a potential downside of 4.00%. Given Advanced Medical Solutions Group's stronger consensus rating and higher probable upside, analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Tristel has a beta of 0.346, meaning that its share price is 65% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.704, meaning that its share price is 30% less volatile than the broader market.

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.3%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

In the previous week, Advanced Medical Solutions Group had 1 more articles in the media than Tristel. MarketBeat recorded 1 mentions for Advanced Medical Solutions Group and 0 mentions for Tristel. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Tristel	Neutral
Advanced Medical Solutions Group	Positive

Tristel has a net margin of 15.88% compared to Advanced Medical Solutions Group's net margin of 4.35%. Tristel's return on equity of 23.64% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
Advanced Medical Solutions Group	4.35%	3.87%	2.35%

Summary

Advanced Medical Solutions Group beats Tristel on 11 of the 18 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to EKF Diagnostics?

Advanced Medical Solutions Group (LON:AMS) and EKF Diagnostics (LON:EKF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

Advanced Medical Solutions Group presently has a consensus target price of GBX 270.25, suggesting a potential downside of 4.00%. EKF Diagnostics has a consensus target price of GBX 35, suggesting a potential upside of 37.80%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe EKF Diagnostics is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, EKF Diagnostics had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat EKF Diagnostics' score of 0.34 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EKF Diagnostics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Advanced Medical Solutions Group has a beta of 0.704, indicating that its share price is 30% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

22.7% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 40.0% of EKF Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Advanced Medical Solutions Group has a net margin of 4.35% compared to EKF Diagnostics' net margin of 4.12%. Advanced Medical Solutions Group's return on equity of 3.87% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
EKF Diagnostics	4.12%	3.01%	5.27%

Advanced Medical Solutions Group has higher revenue and earnings than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28
EKF Diagnostics	£51.56M	2.12	£4.68M	£0.47	54.04

Summary

Advanced Medical Solutions Group beats EKF Diagnostics on 11 of the 16 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to INSPECS Group?

Advanced Medical Solutions Group (LON:AMS) and INSPECS Group (LON:SPEC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Advanced Medical Solutions Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28
INSPECS Group	£191.70M	0.52	-£4.11M	-£9.40	N/A

Advanced Medical Solutions Group has a net margin of 4.35% compared to INSPECS Group's net margin of -2.67%. Advanced Medical Solutions Group's return on equity of 3.87% beat INSPECS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
INSPECS Group	-2.67%	-6.07%	0.45%

Advanced Medical Solutions Group currently has a consensus target price of GBX 270.25, suggesting a potential downside of 4.00%. INSPECS Group has a consensus target price of GBX 60, suggesting a potential downside of 34.78%. Given Advanced Medical Solutions Group's higher probable upside, analysts clearly believe Advanced Medical Solutions Group is more favorable than INSPECS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
INSPECS Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Advanced Medical Solutions Group has a beta of 0.704, meaning that its share price is 30% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.607, meaning that its share price is 61% more volatile than the broader market.

22.7% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 0.7% of INSPECS Group shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 19.6% of INSPECS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Advanced Medical Solutions Group had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for Advanced Medical Solutions Group and 0 mentions for INSPECS Group. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat INSPECS Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Medical Solutions Group	Positive
INSPECS Group	Neutral

Summary

Advanced Medical Solutions Group beats INSPECS Group on 13 of the 16 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Creo Medical Group?

Advanced Medical Solutions Group (LON:AMS) and Creo Medical Group (LON:CREO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Advanced Medical Solutions Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28
Creo Medical Group	£6M	10.53	-£25.04M	£1.00	13.00

Advanced Medical Solutions Group has a beta of 0.704, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Creo Medical Group has a beta of 1.563854, indicating that its stock price is 56% more volatile than the broader market.

In the previous week, Advanced Medical Solutions Group and Advanced Medical Solutions Group both had 1 articles in the media. Advanced Medical Solutions Group's average media sentiment score of 1.12 beat Creo Medical Group's score of 0.75 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Creo Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Advanced Medical Solutions Group presently has a consensus price target of GBX 270.25, indicating a potential downside of 4.00%. Creo Medical Group has a consensus price target of GBX 40, indicating a potential upside of 207.69%. Given Creo Medical Group's higher possible upside, analysts clearly believe Creo Medical Group is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Creo Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Creo Medical Group has a net margin of 88.33% compared to Advanced Medical Solutions Group's net margin of 4.35%. Creo Medical Group's return on equity of 9.56% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
Creo Medical Group	88.33%	9.56%	-20.09%

22.7% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 44.1% of Creo Medical Group shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 7.0% of Creo Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Advanced Medical Solutions Group beats Creo Medical Group on 8 of the 15 factors compared between the two stocks.

Get Advanced Medical Solutions Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMS vs. The Competition

Export

Metric	Advanced Medical Solutions Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	LON Exchange
Market Cap	£612.59M	£5.78B	£7.28B	£2.90B
Dividend Yield	1.02%	1.74%	2.54%	6.14%
P/E Ratio	62.28	26.43	271.52	367.86
Price / Sales	2.68	69.04	631.50	83,482.27
Price / Cash	7.87	33.51	78.13	27.89
Price / Book	2.48	6.15	13.44	7.17
Net Income	£11.22M	£149.51M	£3.46B	£5.89B
7 Day Performance	0.36%	1.22%	2.24%	0.36%
1 Month Performance	0.36%	6.92%	5.14%	3.08%
1 Year Performance	36.66%	9.88%	27.85%	22.79%

Advanced Medical Solutions Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMS Advanced Medical Solutions Group	1.2324 of 5 stars	GBX 281.52 +0.0%	GBX 270.25 -4.0%	+36.0%	£612.59M	£228.94M	62.28	10
NIOX NIOX Group	2.1523 of 5 stars	GBX 66 +3.1%	GBX 86 +30.3%	-0.9%	£277.77M	£48.70M	40.24	92	Gap Down
TSTL Tristel	N/A	GBX 410 flat	N/A	+14.3%	£196.79M	£49.54M	25.25	208
EKF EKF Diagnostics	2.6665 of 5 stars	GBX 25.33 -2.6%	GBX 35 +38.2%	-3.5%	£108.91M	£51.56M	53.89	356	News Coverage Gap Down
SPEC INSPECS Group	0.5654 of 5 stars	GBX 94 -3.1%	GBX 60 -36.2%	+116.1%	£102.62M	£191.70M	N/A	1,673	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:AMS) was last updated on 8/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Advanced Medical Solutions Group (AMS) Competitors

AMS vs. NIOX, TSTL, EKF, SPEC, and CREO

How does Advanced Medical Solutions Group compare to NIOX Group?

Summary

How does Advanced Medical Solutions Group compare to Tristel?

Summary

How does Advanced Medical Solutions Group compare to EKF Diagnostics?

Summary

How does Advanced Medical Solutions Group compare to INSPECS Group?

Summary

How does Advanced Medical Solutions Group compare to Creo Medical Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMS vs. The Competition

Advanced Medical Solutions Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Advanced Medical Solutions Group (AMS) Competitors

AMS vs. NIOX, TSTL, EKF, SPEC, and CREO

How does Advanced Medical Solutions Group compare to NIOX Group?

Do analysts prefer AMS or NIOX?

Which has more volatility & risk, AMS or NIOX?

Which has better earnings & valuation, AMS or NIOX?

Do insiders and institutionals hold more shares of AMS or NIOX?

Does the media favor AMS or NIOX?

Is AMS or NIOX a better dividend stock?

Is AMS or NIOX more profitable?

Summary

How does Advanced Medical Solutions Group compare to Tristel?

Which has better valuation & earnings, TSTL or AMS?

Do institutionals & insiders hold more shares of TSTL or AMS?

Do analysts rate TSTL or AMS?

Which has more risk and volatility, TSTL or AMS?

Is TSTL or AMS a better dividend stock?

Does the media refer more to TSTL or AMS?

Is TSTL or AMS more profitable?

Summary

How does Advanced Medical Solutions Group compare to EKF Diagnostics?

Do analysts prefer AMS or EKF?

Does the media favor AMS or EKF?

Which has more volatility and risk, AMS or EKF?

Do institutionals and insiders have more ownership in AMS or EKF?

Is AMS or EKF more profitable?

Which has stronger valuation and earnings, AMS or EKF?

Summary

How does Advanced Medical Solutions Group compare to INSPECS Group?

Which has stronger earnings and valuation, AMS or SPEC?

Is AMS or SPEC more profitable?

Do analysts prefer AMS or SPEC?

Which has more volatility & risk, AMS or SPEC?

Do insiders & institutionals hold more shares of AMS or SPEC?

Does the media prefer AMS or SPEC?

Summary

How does Advanced Medical Solutions Group compare to Creo Medical Group?

Which has stronger earnings and valuation, AMS or CREO?

Which has more volatility & risk, AMS or CREO?

Does the media prefer AMS or CREO?

Do analysts recommend AMS or CREO?

Is AMS or CREO more profitable?

Do institutionals & insiders believe in AMS or CREO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMS vs. The Competition

Advanced Medical Solutions Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools